» Articles » PMID: 21498513

Competing Interactions Stabilize Pro- and Anti-aggregant Conformations of Human Tau

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2011 Apr 19
PMID 21498513
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Aggregation of Tau into amyloid-like fibrils is a key process in neurodegenerative diseases such as Alzheimer. To understand how natively disordered Tau stabilizes conformations that favor pathological aggregation, we applied single-molecule force spectroscopy. Intramolecular interactions that fold polypeptide stretches of ~19 and ~42 amino acids in the functionally important repeat domain of full-length human Tau (hTau40) support aggregation. In contrast, the unstructured N terminus randomly folds long polypeptide stretches >100 amino acids that prevent aggregation. The pro-aggregant mutant hTau40ΔK280 observed in frontotemporal dementia favored the folding of short polypeptide stretches and suppressed the folding of long ones. This trend was reversed in the anti-aggregant mutant hTau40ΔK280/PP. The aggregation inducer heparin introduced strong interactions in hTau40 and hTau40ΔK280 that stabilized aggregation-prone conformations. We show that the conformation and aggregation of Tau are regulated through a complex balance of different intra- and intermolecular interactions.

Citing Articles

Initiation and modulation of Tau protein phase separation by the drug suramin.

Prince P, Hochmair J, Brognaro H, Gevorgyan S, Franck M, Schubert R Sci Rep. 2023; 13(1):3963.

PMID: 36894559 PMC: 9997437. DOI: 10.1038/s41598-023-29846-9.


Viscoelastic damage evaluation of the axon.

Hasan F, Mahmud K, Khan M, Adnan A Front Bioeng Biotechnol. 2022; 10:904818.

PMID: 36277388 PMC: 9583024. DOI: 10.3389/fbioe.2022.904818.


The Role of Post-Translational Modifications on the Structure and Function of Tau Protein.

Ye H, Han Y, Li P, Su Z, Huang Y J Mol Neurosci. 2022; 72(8):1557-1571.

PMID: 35325356 DOI: 10.1007/s12031-022-02002-0.


Phage display derived peptides for Alzheimer's disease therapy and diagnosis.

Zhang X, Zhang X, Gao H, Qing G Theranostics. 2022; 12(5):2041-2062.

PMID: 35265198 PMC: 8899571. DOI: 10.7150/thno.68636.


NMR Studies of Tau Protein in Tauopathies.

Kitoka K, Skrabana R, Gasparik N, Hritz J, Jaudzems K Front Mol Biosci. 2021; 8:761227.

PMID: 34859051 PMC: 8632555. DOI: 10.3389/fmolb.2021.761227.


References
1.
Berriman J, Serpell L, Oberg K, Fink A, Goedert M, Crowther R . Tau filaments from human brain and from in vitro assembly of recombinant protein show cross-beta structure. Proc Natl Acad Sci U S A. 2003; 100(15):9034-8. PMC: 166433. DOI: 10.1073/pnas.1530287100. View

2.
Sen P, Shalloway D, RACKER E . Phosphorylation of tau protein by purified p34cdc28 and a related protein kinase from neurofilaments. J Biol Chem. 1992; 267(27):19705-9. View

3.
Evans E . Probing the relation between force--lifetime--and chemistry in single molecular bonds. Annu Rev Biophys Biomol Struct. 2001; 30:105-28. DOI: 10.1146/annurev.biophys.30.1.105. View

4.
Barghorn S, Biernat J, Mandelkow E . Purification of recombinant tau protein and preparation of Alzheimer-paired helical filaments in vitro. Methods Mol Biol. 2005; 299:35-51. DOI: 10.1385/1-59259-874-9:035. View

5.
Capila I, Linhardt R . Heparin-protein interactions. Angew Chem Int Ed Engl. 2002; 41(3):391-412. DOI: 10.1002/1521-3773(20020201)41:3<390::aid-anie390>3.0.co;2-b. View